Based on the ability of TNC to promote tumor development, the high expression of TNC in CAFs is an independent prognostic marker for multiple cancers, including breast cancer [147], bladder cancer [148], prostate cancer [45], CRC (especially stage II and III CRC) [149, 150], and pancreatic cancer [151]. The gene discussed is TNC; the disease is prostate carcinoma.